EICHORCondition: CLL · Sponsor: BeOne Medicines
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The main objective of this study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia (CLL)
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Alaska Oncology and Hematology, Llc | Anchorage, Alaska, United States | — |
| City of Hope National Medical Center | Duarte, California, United States | — |
| University of California San Diego (Ucsd) Moores Cancer Center | La Jolla, California, United States | — |
| Valkyrie Clinical Trials | Los Angeles, California, United States | — |
| UCLA Department of Medicine Hematologyoncology | Los Angeles, California, United States | — |
| Chao Family Comprehensive Cancer Center | Orange, California, United States | — |
| Stanford Medicine | Palo Alto, California, United States | — |
| University of Colorado Cancer Center | Aurora, Colorado, United States | — |
| Medstar Georgetown University Hospital | Washington D.C., District of Columbia, United States | — |
| Mount Sinai Medical Center Braman Comprehensive Cancer Center | Miami, Florida, United States | — |
| Moffitt Cancer Center | Tampa, Florida, United States | — |
| Southeastern Regional Medical Center | Newnan, Georgia, United States | — |
+ 189 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06073821